- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.12. | Venus Concept Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.11. | Venus Concept targets sequential Q4 growth with Venus NOVA launch amid Venus Hair sale uncertainty | 1 | Seeking Alpha | ||
| 13.11. | Venus Concept Inc. Q3 Sales Decline | 3 | RTTNews | ||
| 13.11. | Venus Concept GAAP EPS of -$12.14, revenue of $13.78M | 3 | Seeking Alpha | ||
| 13.11. | Venus Concept Inc.: Venus Concept Announces Third Quarter 2025 Financial Results | 233 | GlobeNewswire (Europe) | TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three... ► Artikel lesen | |
| VENUS CONCEPT Aktie jetzt für 0€ handeln | |||||
| 13.11. | Venus Concept Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 13.11. | Venus Concept Inc. - 8-K, Current Report | - | SEC Filings | ||
| 10.11. | Venus Concept Inc.: Venus Concept Receives 510(k) for the Venus NOVA, Its Most Advanced Multi-Application Platform for Non-Invasive Body and Skin Treatments | 148 | GlobeNewswire (Europe) | TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company"), a global leader in medical aesthetic technology, announced today that it has received a 510(k) clearance... ► Artikel lesen | |
| 31.10. | Venus Concept Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 02.10. | Venus Concept announces $11.48 million debt-to-equity exchange transaction | 1 | Seeking Alpha | ||
| 02.10. | Venus Concept Inc.: Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transaction | 122 | GlobeNewswire (Europe) | TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that, on September 30... ► Artikel lesen | |
| 02.10. | Venus Concept Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.10. | Venus Concept Inc.: Venus Concept to Release Third Quarter of Fiscal Year 2025 Financial Results on November 13, 2025 | 3 | GlobeNewswire (USA) | ||
| 22.09. | Venus Concept sichert sich Darlehen über 2 Mio. USD und genehmigt Boni für Führungskräfte | 1 | Investing.com Deutsch | ||
| 22.09. | Venus Concept Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.09. | Venus Concept Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 26.08. | Venus Concept Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 15.08. | Venus Concept outlines $20M hair business sale while targeting core aesthetics growth amid challenging environment | 2 | Seeking Alpha | ||
| 14.08. | Venus Concept Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 14.08. | Venus Concept Inc.: Venus Concept Announces Second Quarter 2025 Financial Results | 170 | GlobeNewswire (Europe) | TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three... ► Artikel lesen |
1 2 Weiter >>
38 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 47,560 | -0,73 % | AKTIEN IM FOKUS: Medizintechnikwerte von Exane bewegt - 'Zweigeteiltes 2026' | FRANKFURT (dpa-AFX) - Die Aktien von Siemens Healthineers und Sartorius haben am Mittwoch nach einer Studie von Exane BNP Paribas zum europäischen Medizintechniksektor unterschiedliche Richtungen eingeschlagen.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,130 | +0,53 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,050 | -1,63 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| UNITEDHEALTH | 291,40 | +0,07 % | Dividendenbekanntmachungen (08.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGRICULTURAL BANK OF CHINA LTD ADR US00850M1027 0,4197 USD 0,3605 EUR ALPHABET INC CDR CA02080K1049 0,0339 CAD 0,0211 EUR ALPHABET... ► Artikel lesen | |
| TELADOC HEALTH | 6,431 | -0,08 % | Teladoc Health, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| THERMO FISHER | 486,85 | -0,11 % | Thermo Fisher upgraded at Citi on boost in pharma spending | ||
| ROKU | 91,61 | +0,05 % | Streaming im Wandel: Warum sich bei Roku ein Blick lohnt und RTL+ und Joyn um Markanteile kämpfen. | Die Roku-Aktie hat seit Jahresbeginn bereits über 42?% zugelegt - Analysten wie Jefferies sehen dennoch weiteres Aufwärtspotenzial von bis zu 28?%. Während Roku mit Plattformwachstum und Kostenkontrolle... ► Artikel lesen | |
| BICO GROUP | 1,716 | 0,00 % | BICO Group AB: Ewa Linsäter appointed as Chief Financial Officer for BICO Group AB | BICO Group AB today announces the appointment of Ewa Linsäter as Chief Financial Officer. She will succeed Jacob Thordenberg, who has decided to leave BICO to pursue his career outside the Group.
Ewa... ► Artikel lesen | |
| PLUS THERAPEUTICS | 0,684 | -5,03 % | Plus Therapeutics Inc.: Plus Therapeutics Expands CNSide Assay Platform to State of California | ||
| RESMED | 214,10 | -0,37 % | Resmed Gets FDA Clearance For Personalized Therapy Comfort Settings; To Be Marketed As Smart Comfort | WASHINGTON (dpa-AFX) - Resmed (RMD, RMD.AX), Monday announced it has received U.S. Food and Drug Administration (FDA) clearance for Personalized Therapy Comfort Settings (PTCS), to be marketed... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,780 | +11,11 % | Atossa Therapeutics Inc: Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation for (Z)-Endoxifen for Duchenne Muscular Dystrophy | Designation expands (Z)-Endoxifen program into rare pediatric neuromuscular disease and may qualify Atossa for a future Priority Review Voucher upon approval
SEATTLE... ► Artikel lesen | |
| HENRY SCHEIN | 65,00 | -0,31 % | HENRY SCHEIN INC - 8-K, Current Report | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,030 | +0,94 % | Starke Kursanstiege - AJN Resources, Delivery Hero, Siemens Healthineers | Ein massiver Stellenabbau betrifft nicht nur die deutsche Wirtschaft, auch in der Schweiz sind Umstrukturierungen erforderlich, um sich den Marktgegebenheiten anzupassen. Nach der überstürzten Übernahme... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,360 | -0,31 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen |
VENUS CONCEPT INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 1,627 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENUS CONCEPT INC finden Sie auf Wallstreet Online.